Eve-Lyne Marchand, Ph.D.
Affiliations: | 2003 | Université de Montréal, Montréal, Canada |
Area:
Pharmacology, Cell Biology, PathologyGoogle:
"Eve-Lyne Marchand"Parents
Sign in to add mentor| Denis deBlois | grad student | 2003 | Université de Montréal | |
| (Role de l'apoptose des cellules aortiques et cardiaques en reponse a un traitement antihypertenseur avec un antagoniste des recepteurs AT(1) de l'angiotensine II.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dutil J, Eliopoulos V, Marchand EL, et al. (2005) A quantitative trait locus for aortic smooth muscle cell number acting independently of blood pressure: Implicating the angiotensin receptor AT1B gene as a candidate Physiological Genomics. 21: 362-369 |
| Der Sarkissian S, Marchand EL, Duguay D, et al. (2004) Synergistic interaction between enalapril, L-arginine and tetrahydrobiopterin in smooth muscle cell apoptosis and aortic remodeling induction in SHR. British Journal of Pharmacology. 142: 912-8 |
| Marchand EL, Der Sarkissian S, Hamet P, et al. (2003) Caspase-dependent cell death mediates the early phase of aortic hypertrophy regression in losartan-treated spontaneously hypertensive rats. Circulation Research. 92: 777-84 |
| Der Sarkissian S, Marchand EL, Duguay D, et al. (2003) Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril. Cardiovascular Research. 57: 775-83 |
| Marchand E, Der Sarkissian S, Hamet P, et al. (2001) Caspase-dependent cell death of non-carmyocytes in losartan-treated SHR Journal of Molecular and Cellular Cardiology. 33: A73 |